Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: COMBINATION_PRODUCT: pyrotinib maleate tablets+nab-paclitaxel
Sponsor: Hebei Medical University Fourth Hospital